FIGS (FIGS) is back in focus after reporting quarterly results that exceeded analyst expectations. The company reported broad-based sales growth, improved margins, strong cash flow, and raised its 2026 net revenue growth guidance.

Despite the strong quarterly report and higher 2026 revenue guidance, FIGS’ recent share price performance has been mixed, with the stock down over the past quarter but supported by a 1-year total shareholder return of about 121%. This suggests that longer term momentum remains more positive.

If FIGS’ move has caught your attention, it can be useful to see how other growth stories are shaping up in healthcare. Take a look at 39 healthcare AI stocks

With FIGS shares down over the past quarter but still carrying a roughly 121% 1 year total return and trading at a discount to analyst targets, the key question is whether this is a fresh opportunity or if future prospects are already reflected in the current price.

Most Popular Narrative: 18.5% Undervalued

According to the most followed narrative on FIGS, a fair value of $14.08 compares to the last close at $11.48, implying meaningful upside in the current set up.

The company, on an absolute basis, is still growing well. Further, it has several growth levers, such as expanding its product range, entering new markets, and leaning into its “TEAMS” offering.

Want to see what sits behind that valuation gap? The narrative focuses on rising margins, steady revenue growth and a premium future profit multiple. Curious how those inputs combine into a $14.08 fair value and an 18.5% discount? The full narrative lays out every assumption.

Result: Fair Value of $14.08 (UNDERVALUED)

However, there are clear swing factors to watch. These include execution risk around maintaining margin progress and the potential impact of economic weakness on FIGS’ premium positioning.

Another Take: Rich Multiples Versus Undervalued Narrative

The user narrative points to undervaluation at a $14.08 fair value, but the current P/E of 47.2x tells a different story. That level is roughly double the US Luxury industry at 23.7x and the peer average at 22.6x. It also sits well above the 22x fair ratio our model suggests the market could move toward. For investors, that gap can mean paying up for quality or taking on higher valuation risk than the narrative implies.

To pressure test this, it is worth seeing what the numbers say next in the valuation breakdown, including how that fair ratio is derived and how peers line up today, via See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment leaning positive but valuation questions still on the table, now is a good time to review the data yourself and pressure test the bullish rewards case. To see exactly what is driving that optimism, take a closer look at the 3 key rewards.

Looking for more investment ideas?

If FIGS has sharpened your focus, now is the moment to widen your watchlist with other opportunities that match different goals and risk levels.

Use the Simply Wall Street Screener to uncover stocks that might otherwise slip past your radar and keep your next move firmly on the front foot.

• Target stability and resilience by screening for 63 resilient stocks with low risk scores that aim to keep portfolio volatility in check.
• Hunt for quality at a reasonable price by scanning 47 high quality undervalued stocks that combine strong fundamentals with pricing that may appeal.
• Strengthen your income and growth mix by focusing on 9 dividend fortresses that pair higher yields with an emphasis on durability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.